Bayer
Clinical trials sponsored by Bayer, explained in plain language.
-
New pill hopes to boost immune system against tough cancers
Disease control OngoingThis early-stage study tests a new drug, BAY 2965501, that aims to activate the body's immune T-cells to fight advanced solid tumors (like certain skin, kidney, stomach, and lung cancers). The study involves about 284 participants and will test the drug alone or combined with oth…
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for breast cancer patients: drug targets treatment-induced hot flashes
Symptom relief OngoingThis study tests a new drug, elinzanetant, to see if it can reduce hot flashes in women with hormone-receptor positive breast cancer who are on hormone-blocking therapy. About 474 women will take either the drug or a placebo for 12 weeks, then all will receive the drug for up to …
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Massive data dive: sepsis Patients' hidden clot risk revealed
Knowledge-focused OngoingThis study looks at medical records from 10,000 people who had sepsis (blood poisoning) and blood clots in their veins (VTE) while in the ICU. Researchers want to see if a serious clotting disorder called DIC happened before the blood clots formed. No new treatments or tests are …
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC